Drug delivery strategies with lipid-based nanoparticles for Alzheimer’s disease treatment
Abstract Alzheimer's disease (AD) is a distinctive form of dementia characterized by age-related cognitive decline and memory impairment. A key hallmark of AD is the irreversible overaccumulation of beta-amyloid (Aβ) in the brain, associated with neuroinflammation and neuronal death. Although A...
Saved in:
| Main Authors: | Young-Ju Jang, Seong-Jun Kang, Hyun Su Park, Dong-Hyun Lee, Jae Hoon Kim, Ju-El Kim, Dong-Ik Kim, Chan-Hwa Chung, Jeong-Kee Yoon, Suk Ho Bhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Series: | Journal of Nanobiotechnology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12951-025-03109-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exosome-Mediated Mitochondrial Regulation: A Promising Therapeutic Tool for Alzheimer’s Disease and Parkinson’s Disease
by: Jung YH, et al.
Published: (2025-04-01) -
Intranasal Delivery of BACE1 siRNA and Berberine via Engineered Stem Cell Exosomes for the Treatment of Alzheimer’s Disease
by: Sun C, et al.
Published: (2025-05-01) -
Montbretia flowers as a source of bioactive crocins: Biotechnology tools and delivery systems
by: Lucía Morote, et al.
Published: (2025-06-01) -
Targeted Delivery Strategies for Hydrophilic Phytochemicals
by: Marta Sharafan, et al.
Published: (2025-06-01) -
Scouting Biomarkers for Alzheimer’s Disease via Network Analysis of Exosome Proteomics Data
by: Alexis Sagonas, et al.
Published: (2025-04-01)